BIOTEST AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.8 EUR | -0.48% |
|
-0.48% | -1.88% |
| Sales 2024 * | 636M 675M | Sales 2025 * | 712M 756M | Capitalization | 1.4B 1.49B |
|---|---|---|---|---|---|
| Net income 2024 * | -4M -4.25M | Net income 2025 * | 59M 62.67M | EV / Sales 2024 * | 3.24 x |
| Net Debt 2024 * | 661M 702M | Net Debt 2025 * | 663M 704M | EV / Sales 2025 * | 2.9 x |
| P/E ratio 2024 * |
-283
x | P/E ratio 2025 * |
19.2
x | Employees | 2,426 |
| Yield 2024 * |
0.07% | Yield 2025 * |
2.16% | Free-Float | 29.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Biotest AG
More press releases
More news
| 1 day | -0.95% | ||
| 1 week | +0.48% | ||
| Current month | -0.94% | ||
| 1 month | +0.96% | ||
| 3 months | -0.94% | ||
| 6 months | -1.41% | ||
| Current year | -1.41% |
1 week
41.80
42.40
1 month
41.2043.00
Current year
40.4043.00
1 year
39.6044.00
3 years
27.6044.60
5 years
17.2044.60
10 years
11.7044.60
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 41.8 | -0.48% | 0 |
| 24-04-15 | 42 | 0.00% | 28 |
| 24-04-12 | 42 | +0.48% | 100 |
| 24-04-11 | 41.8 | -0.48% | 100 |
| 24-04-10 | 42 | 0.00% | 2 |
Delayed Quote Xetra, April 15, 2024 at 11:36 am EDT
More quotes
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Sector
Pharmaceuticals
Calendar
2024-05-06
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
28.8
EUR
Average target price
37
EUR
Spread / Average Target
+28.47%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.17% | 86.99B | |
| +4.34% | 40.68B | |
| -23.95% | 28.61B | |
| +50.57% | 24.1B | |
| -5.09% | 17.37B | |
| -32.11% | 13.72B | |
| -5.10% | 12.49B | |
| -14.91% | 12B | |
| -5.92% | 7.94B |
- Stock Market
- Equities
- BIO3 Stock
- BIO Stock
